查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1840725

冠狀動脈支架市場按產品類型、材料、塗層、應用、最終用戶和分銷管道分類－2025-2032 年全球預測

Coronary Stents Market by Product Type, Material, Coating, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，冠狀動脈支架市場將成長至 211.4 億美元，複合年成長率為 10.78%。

主要市場統計數據
基準年2024年 93.1億美元
預計2025年 103億美元
預測年份：2032年 211.4億美元
複合年成長率（%） 10.78%

介紹性概述，重點介紹影響冠狀動脈支架採用和採購的設備類別、臨床要求和策略價值槓桿

冠狀動脈支架領域正處於快速臨床創新與不斷發展的交付模式的交匯點，因此需要一個入門框架來闡明其範圍、術語和戰略要點。本介紹概述了最新的器械類別、材料科學的進展、操作考慮以及影響介入性心臟病學技術應用的相關人員生態系統。透過區分傳統設計和新一代平台，並解釋臨床證據、報銷動態和醫院採購慣例如何共同影響器械選擇，從而建立基礎理解。

引言也將冠狀動脈支架納入了急性冠狀動脈症候群的更廣泛治療途徑，強調經經皮冠狀動脈介入治療仍然是最小化梗塞面積、恢復灌注和改善長期療效的核心。引言從行業角度探討了聚合物技術、藥物釋放型曲線和支架設計的逐步改進如何有助於減少血管再阻塞和改善內皮化，並強調了監管和強力的上市後監測的必要性。

最後，引言透過確定製造商和醫療保健系統的關鍵價值槓桿（臨床差異化、成本效率、供應鏈彈性和證據生成）為其餘分析組裝，為後續章節探討轉型轉變、關稅影響、細分洞察和區域差異奠定了基礎，使讀者在閱讀報告時有一個明確的目的。

近期的設備創新、採購演變和數據主導的臨床模型如何重新定義冠狀動脈支架領域的競爭差異化

過去五年，器械設計、監管預期和通路動態的變革正在重塑冠狀動脈支架領域的競爭格局。生物可吸收支架化學和低剖面輸送系統的進步，更重視長期血管癒合和晚期管腔預後，迫使臨床醫生重新評估器械選擇標準，而不僅僅是短期手術成功率。同時，聚合物創新正在實現更一致的藥物洗脫動力學，降低血管再阻塞率，並支持第二代藥物洗脫平台的廣泛應用。

同時，付款方和醫院的籌資策略也變得更加複雜，強調總成本和基於價值的契約，而不僅僅是單位成本。這種轉變有利於那些能夠證明持久臨床效益、可預測庫存管理和靈活商業模式（包括直銷和經銷商合作）的製造商。此外，門診手術中心和門診介入室的興起，也催生了對精簡庫存套件和設備的需求，這些套件和設備能夠支援快速週轉、高效滅菌和簡單的臨床醫生培訓。

最後，數位健康與數據驅動的上市後監測的整合正在改變競爭動態。能夠提供遠端監控、註冊支援和真實世界證據管道的製造商正在贏得循環系統領導者和付款人的信任。因此，市場正在從單純的設備功能競爭轉向將臨床結果與提供者效率相結合的整合服務模式的競爭。

評估2025年美國關稅調整如何增強供應鏈策略、採購本地化和採購總成本考量

2025年美國關稅政策的轉變，為製造商、經銷商和醫院採購團隊的營運環境帶來了新的變數。其累積效應進一步凸顯了供應鏈彈性、採購多角化和貼近市場的製造能力的重要性。重要的是，雖然關稅並未改變臨床表現預期，但它確實改變了跨境採購的經濟性，並改變了關鍵零件和成品產地的計算方式。

因此，許多相關人員正在加快供應商資格審查流程，以確保供應的連續性，並降低投入成本突然波動的風險。這促使人們重新重視有效的多源採購策略和區域製造佈局，以降低關稅波動帶來的風險。同時，採購部門正在進行更詳細的總擁有成本分析，將關稅、物流和庫存持有成本納入考量，並日益嚴格地審查與直銷團隊和分銷商合作夥伴簽訂的合約條款。

臨床醫生和醫院管理人員對此的回應是，優先考慮兼具臨床可靠性和可預測供應的設備組合。因此，能夠提供透明採購路線圖、本地化計劃和強大服務水準協議的製造商正受到更青睞。最後，關稅環境促使人們討論戰略夥伴關係和聯合製造安排，以穩定供應，同時確保負責人和患者能夠獲得最尖端科技。

整合細分洞察，將產品設計、材料科學、塗層策略、臨床應用、最終用戶需求和分銷模式連結起來，實現策略協調

特定細分市場的動態揭示了產品設計、材料成分、塗層策略、臨床應用、最終用戶設定和通路等方面的差異化需求向量。按產品類型分類，裸金屬支架在某些需要簡單支架和低成本解決方案的臨床場景中仍然發揮著傳統作用，而生物可吸收血管支架因其具有隨時間推移恢復原生血管生理功能的潛力而越來越受到人們的關注。藥物釋放型支架在複雜病變中仍然占主導地位，而聚合物塗層支架則根據洗脫藥物進一步細分，例如Everolimus、Sirolimus和佐他莫司。無聚合物選項適用於對耐用聚合物敏感的患者。鈷鉻合金在強度和滲透性之間取得平衡，而鎳鈦諾則提供超彈性，非常適合曲折的解剖結構。當成本和可製造性是主要考慮因素時，不銹鋼是首選。

塗層策略與聚合物科學和藥物化學相互交織，決定了癒合反應和血管再阻塞風險。當控制釋放至關重要時，聚合物塗層器械仍然很受歡迎；無聚合物支架則吸引尋求減少聚合物暴露的特定患者群體；而無塗層平台則專用於特定適應症，這些適應症優先考慮機械支撐而無需藥物調整。用於急性心肌梗塞的器械必須優先考慮快速部署和抗血栓性，而用於慢性冠狀動脈疾病的平台則強調長期通暢性和治療後安全性。門診手術中心優先考慮緊湊的庫存和便捷性，心臟中心需要利基專用器械，而醫院則需要廣泛的SKU深度和即時用於緊急干預的庫存。分銷管道決定了商業執行，因為直銷可以實現密切的臨床參與和培訓，分銷商提供廣泛的覆蓋範圍和庫存管理，而線上管道擴大支持機構買家補貨和產品資訊。這些細分市場之間的相互作用構成了一個複雜的矩陣，製造商必須駕馭它，以使產品設計、臨床證據產生和上市模式與相關人員的需求保持一致。

美洲、歐洲、中東和非洲以及亞太地區的戰略需求和差異化的市場動態推動了採用和商業性執行

區域動態對冠狀動脈支架的臨床實務模式、監管途徑和商業性執行有重大影響。在美洲，介入性心臟病學的卓越中心、密集的醫院網路以及以結果為導向的支付方，為先進的藥物釋放型平台和強大的上市後證據項目創造了肥沃的土壤。該地區的採購週期往往強調捆綁式醫療指標，因此臨床數據和服務交付成為談判的關鍵要素。由於公立和私立醫院在某些市場優先考慮成本控制，而在其他市場則對尖端醫療設備的需求旺盛，製造商必須調整其價值文件和本地臨床夥伴關係關係，以滿足國家層面的期望。

在亞太地區，手術量的快速成長、介入服務覆蓋範圍的不斷擴大以及多樣化的醫療服務模式既帶來了機遇，也帶來了營運的複雜性。本地製造和戰略許可在該地區尤其重要，因為監管時間表和進口考慮會影響採用速度。在每個地區，都市區三級醫療中心與分散服務之間的互動都會影響SKU的合理化和培訓投資。因此，商業策略必須因地制宜，在集中式臨床證據產生和分散式執行能力之間取得平衡，以最佳化採用率並與醫療系統和臨床醫生保持長期合作關係。

主要企業如何結合臨床證據、製造敏捷性和多通路商業模式來確保競爭優勢和醫療保健提供者的信任

冠狀動脈支架生態系統的主要企業透過臨床證據、材料創新、商業卓越和服務的結合脫穎而出。投資於隨機試驗和大規模註冊的領先製造商能夠提升臨床醫生的信心和醫院的接受度，而那些透過培訓計劃和數據管理服務補充其設備產品的製造商則能夠提高其在複雜治療中心的滲透率。設備製造商和契約製造製造商之間的策略聯盟加快了新合金和塗層製程的上市時間，並使其能夠更靈活地回應臨床醫生的回饋和監管諮詢。

此外，競爭優勢也越來越依賴多通路交付。成功將直銷與經銷商網路和數位訂購平台結合的公司能夠實現更廣泛的覆蓋範圍和更穩定的庫存績效。其他公司則利用本地生產和區域監管專業知識來縮短訂單前置作業時間。總而言之，差異化不在於單一產品的優勢，而是提供一致臨床結果、可靠的供應連續性以及將設備整合到醫療機構工作流程中的支援性服務模式的能力。

為設備製造商和商業領袖提供高影響力的建議，以增強臨床差異化、供應彈性和基於價值的採用

針對行業領導者的可行建議強調了加強臨床差異化、供應彈性和商業性相關性的切實步驟：投資於註冊研究和有針對性的隨機試驗，這些研究應在代表性患者群體中證明療效持久且具有成本效益。其次，實現生產和供應網路多元化，以減少貿易政策變化和物流中斷帶來的風險，同時保持嚴格的品質系統和透明的採購資訊揭露，以安撫機構投資者。

第三，我們將根據不同的臨床和最終用戶需求調整產品系列，將設備特性（例如聚合物策略、藥物洗脫曲線和材料成分）與最利於採用的程序環境相結合。第四，我們將擴展商業模式，包括多站點直銷、與經銷商合作以擴大覆蓋範圍，以及用於續藥和產品教育的數位平台。第五，我們將投資於上市後監測和數位工具，以產生真實世界證據並支持臨床醫生培訓。最後，我們將促進支付方和醫療系統之間的協作對話，從整體護理角度而非單位成本來看待醫療設備，從而促成​​對可證明的臨床和經濟價值進行獎勵的協議。實施這些措施將提高市場韌性，並使我們能夠實現持續的臨床應用。

採用穩健的混合方法研究途徑，結合臨床醫師訪談、指南綜合、監管審查和商業管道分析來檢驗結論

本報告背後的調查方法結合了專家定性訪談、系統性文獻評估、監管文件審查和跨職能商業分析，以確保獲得均衡且檢驗的見解。主要研究包括與介入性心臟病專家、醫院採購主管、分銷主管和報銷專家的對話，以了解他們在器械選擇、臨床重點和營運限制方面的專業觀點。這些相關人員的意見與同行評審的臨床文獻、主要心臟病學會指南和公共監管資訊進行了整合，以檢驗臨床聲明並識別新興的安全訊號。

我們的商業分析使用匿名供應商和經銷商資料來繪製典型的市場進入模式、SKU策略和通路績效考量，而我們的供應鏈研究則結合了採購模式和製造足跡，以評估不斷變化的貿易條件下的韌性。我們謹慎地剔除了專有或機密數據，所有解讀均基於可公開檢驗的資訊來源和專家佐證。在整個調查方法中，我們優先考慮假設的透明度、細分的清晰度和分析步驟的可重複性，以確保我們的研究結果能夠可靠地應用於策略、採購和臨床規劃。

總結性結論強調了臨床表現、交付策略和服務整合如何決定長期採用和機構價值

總而言之，冠狀動脈支架產業正處於關鍵時刻，材料科學、聚合物技術和證據生成與不斷變化的採購和監管格局交匯。持久的療效、減少血管再阻塞以及良好的癒合情況將持續影響心臟科醫師的偏好。同時，供應鏈彈性、總擁有成本和區域監管複雜性等經濟和營運因素對醫院和系統採購商也日益具有決定性作用。

因此，將產品創新與已證實的臨床效用、透明的供應策略和服務導向的商業模式相結合的相關人員，將最有可能實現永續的採用。對本地製造、真實世界證據產生和售後整合支援的策略性投資將創造穩固的優勢。最終，市場將青睞那些能夠提供可預測臨床結果，同時無縫融入機構工作流程和付款人期望的解決方案，確保患者受益並實現機構價值。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 增加生物可吸收鎂支架的採用可降低長期血栓症風險
  • 整合藥物釋放型塗層創新技術，標靶治療複雜冠狀動脈病變
  • 擴大機器人輔助經皮冠狀動脈介入治療可提高準確性
  • 同時治療血管再阻塞和癒合的雙療支架的需求不斷增加
  • 使用 3D 成像和 AI 演算法進行患者特異性支架尺寸測量的進展
  • 細支柱鈷鉻支架的市場滲透率提高輸送能力
  • 監管部門的核准擴大了下一代可生物分解聚合物支架的機會
  • 中國和印度擴大公共衛生計畫對冠狀動脈支架消費的影響
  • 支架置入後患者追蹤的遠端監控和數位健康平台的演變
  • 低成本支架製造商之間的競爭趨勢將影響定價策略

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 冠狀動脈支架市場（依產品類型）

  • 裸金屬支架
  • 生物可吸收血管支架
  • 藥物釋放型支架
    • 聚合物塗層
      • Everolimus洗脫
      • Sirolimus洗脫
      • 佐他莫司洗脫
    • 不含聚合物

9. 冠狀動脈支架市場（依材料）

  • 鈷鉻合金
  • 鎳鈦合金
  • 不銹鋼

10. 冠狀動脈支架市場（按塗層）

  • 聚合物塗層
  • 不含聚合物
  • 無塗層

第11章 冠狀動脈支架市場（依應用）

  • 急性心肌梗塞
  • 慢性冠狀動脈疾病

第12章 冠狀動脈支架市場（依最終用戶）

  • 門診手術中心
  • 心臟中心
  • 醫院

13. 冠狀動脈支架市場（依通路）

  • 直銷
  • 經銷商
  • 線上

14. 冠狀動脈支架市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 15 章：冠狀動脈支架市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國心臟支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic plc
    • Terumo Corporation
    • Biotronik SE & Co. KG
    • Cordis Corporation
    • B. Braun Melsungen AG
    • MicroPort Scientific Corporation
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Cook Medical LLC
Product Code: MRR-A339DAEFA3E2

The Coronary Stents Market is projected to grow by USD 21.14 billion at a CAGR of 10.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 9.31 billion
Estimated Year [2025] USD 10.30 billion
Forecast Year [2032] USD 21.14 billion
CAGR (%) 10.78%

Introductory overview that clarifies device categories, clinical imperatives, and strategic value levers shaping adoption and procurement of coronary stents

The coronary stent landscape sits at the intersection of rapid clinical innovation and evolving delivery models, requiring an introductory framing that clarifies scope, terminology, and strategic imperatives. This introduction outlines the contemporary device classes, material science advances, procedural considerations, and the ecosystem of stakeholders that shape technology adoption across interventional cardiology. It establishes a baseline understanding by distinguishing between legacy designs and next-generation platforms, and by explicating how clinical evidence, reimbursement dynamics, and hospital procurement practices converge to influence device selection.

In addition, the introduction situates coronary stents within broader care pathways for acute and chronic coronary syndromes, highlighting how percutaneous coronary intervention remains central to minimizing infarct size, restoring perfusion, and improving long-term outcomes. From an industry perspective, the introduction discusses how incremental improvements in polymer technology, drug elution profiles, and scaffold design contribute to reduced restenosis and improved endothelialization, while also noting regulatory scrutiny and the need for robust post-market surveillance.

Finally, the introduction frames the remainder of the analysis by identifying the principal value levers for manufacturers and health systems: clinical differentiation, cost-effectiveness, supply chain resilience, and evidence generation. This sets expectations for the subsequent sections that explore transformative shifts, tariff impacts, segmentation insights, and regional variations, enabling readers to navigate the report with clarity and purpose.

How recent device innovations, procurement evolution, and data-driven clinical models are collectively redefining competitive differentiation in the coronary stent sector

The past five years have produced transformative shifts in device design, regulatory expectations, and channel dynamics that are reshaping competitive positioning across the coronary stent arena. Advances in bioresorbable scaffold chemistry and low-profile delivery systems have intensified the focus on long-term vascular healing and late lumen outcomes, prompting clinicians to reassess device selection criteria beyond acute procedural success. At the same time, polymer innovations have enabled more consistent drug elution kinetics, reducing rates of restenosis and supporting broader adoption of second-generation drug eluting platforms.

Concurrently, payer and hospital procurement strategies have become more sophisticated, emphasizing total cost of care and value-based contracting rather than unit price alone. This shift has favored manufacturers that can demonstrate durable clinical benefits, predictable inventory management, and flexible commercial models that include direct sales and distributor partnerships. Moreover, the rise of ambulatory surgical centers and outpatient interventional suites has created demand for streamlined inventory sets and devices that support rapid turnover, sterilization efficiency, and straightforward clinician training.

Finally, digital health integrations and data-enabled post-market surveillance are altering competitive dynamics. Manufacturers that can offer remote monitoring, registry support, and real-world evidence pipelines are gaining credibility with cardiology leaders and payers alike. As a result, the market is transitioning from competition on device features alone to competition on integrated service models that align clinical outcomes with institutional efficiency.

Assessment of how United States tariff adjustments in 2025 have intensified supply chain strategy, sourcing localization, and procurement total cost considerations

Policy shifts in 2025 regarding United States tariffs have introduced a new variable into the operating environment for manufacturers, distributors, and hospital procurement teams. The cumulative effect has been to sharpen the focus on supply chain resilience, sourcing diversification, and the importance of near-market manufacturing capabilities. Importantly, tariffs have not altered clinical performance expectations, but they have changed the economics of cross-border sourcing and the calculus for where to manufacture critical components and finished devices.

Consequently, many stakeholders have accelerated supplier qualification processes to ensure continuity of supply and to mitigate the risk of sudden input cost variability. This has led to a renewed emphasis on validated multi-sourcing strategies and regional manufacturing footprints that reduce exposure to tariff volatility. In parallel, procurement organizations have engaged in more detailed total cost of ownership analyses to account for duty, logistics, and inventory carrying costs, leading to greater scrutiny of contractual terms with both direct sales teams and distributor partners.

Clinicians and hospital administrators have reacted by prioritizing device portfolios that combine clinical reliability with predictable supply. As a result, manufacturers that can offer transparent sourcing maps, localization plans, and robust service-level agreements are being viewed more favorably. Finally, the tariff environment has encouraged conversations about strategic partnerships and co-manufacturing arrangements to stabilize supply while preserving access to cutting-edge technologies for proceduralists and patients.

Integrated segmentation insights that connect product design, material science, coating strategies, clinical applications, end-user requirements, and distribution models for strategic alignment

Segment-specific dynamics reveal differentiated demand vectors across product design, material composition, coating strategy, clinical application, end-user setting, and distribution pathways. By product type, the legacy role of bare metal stents persists in certain clinical scenarios where simple scaffolding and low-cost solutions are required, while bioresorbable vascular scaffolds attract interest for their potential to restore native vessel physiology over time; drug eluting stents continue to dominate adoption for complex lesions, with polymer-coated variants further segmented by eluted agents such as everolimus, sirolimus, and zotarolimus, and with polymer-free options positioned for patients with heightened sensitivity to durable polymers. Material choice matters for deliverability and radial strength, with cobalt chromium delivering a balance of strength and radiopacity, nitinol offering superelastic properties favorable for tortuous anatomies, and stainless steel remaining relevant where cost and manufacturability are primary considerations.

Coating strategy intersects with polymer science and drug chemistry to determine healing response and restenosis risk; polymer-coated devices remain prevalent where controlled release is paramount, polymer-free stents appeal in select patient cohorts seeking reduced polymer exposure, and uncoated platforms are reserved for specific indications that prioritize mechanical support without pharmacologic modulation. Application-level segmentation highlights distinct clinical decision trees: devices used for acute myocardial infarction must prioritize rapid deployability and thrombus tolerance, whereas platforms for chronic coronary artery disease emphasize long-term patency and late-outcome safety. End-use environments influence purchasing behavior and inventory management, with ambulatory surgical centers prioritizing compact inventory and simplicity, cardiac centers requiring niche specialty devices, and hospitals demanding broad SKU depth and immediate availability for emergency interventions. Distribution channels shape commercial execution, as direct sales enable close clinical engagement and training, distributors offer breadth of reach and inventory management, and online channels increasingly support replenishment and product information for institutional buyers. Taken together, these segment interactions create an intricate matrix that manufacturers must navigate to align product design, clinical evidence generation, and go-to-market models with stakeholder needs.

Regional strategic imperatives and differentiated market dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive adoption and commercial execution

Regional dynamics exert a profound influence on clinical practice patterns, regulatory pathways, and commercial execution for coronary stents. In the Americas, centers of excellence in interventional cardiology, dense hospital networks, and payers focused on outcomes create fertile ground for advanced drug eluting platforms and robust post-market evidence programs. Procurement cycles in this region tend to emphasize bundled care metrics, making clinical data and service offerings pivotal in negotiations. Moving to Europe, the Middle East & Africa, the regulatory heterogeneity and varied reimbursement landscapes require adaptable market entry strategies; public and private hospitals may prioritize cost containment in some markets while seeking cutting-edge devices in others, so manufacturers must calibrate value dossiers and local clinical partnerships to match country-level expectations.

In the Asia-Pacific region, rapid growth in procedural volumes, expanding access to interventional services, and a diverse mix of healthcare delivery models present both opportunities and operational complexities. Local manufacturing and strategic licensing are especially salient in this region, where regulatory timelines and import considerations can influence adoption speed. Across all regions, the interplay between urban tertiary centers and distributed rural services affects SKU rationalization and training investments. Therefore, commercial strategies should be regionally nuanced, balancing centralized clinical evidence generation with decentralized execution capabilities to optimize adoption and sustain long-term relationships with health systems and clinicians.

How leading companies are combining clinical evidence, manufacturing agility, and multi-channel commercial models to secure competitive advantage and institutional trust

Key companies in the coronary stent ecosystem differentiate themselves through a combination of clinical evidence, material innovation, commercialization sophistication, and service delivery. Leading manufacturers that invest in randomized trials and large registries generate stronger clinician trust and facilitate hospital formulary acceptance, while those that complement device offerings with training programs and data-management services achieve greater penetration in complex treatment centers. Strategic alliances between device makers and contract manufacturers have accelerated time-to-market for novel alloys and coating processes, enabling more agile responses to clinician feedback and regulatory queries.

Moreover, competitive advantage increasingly depends on multi-channel reach; companies that successfully integrate direct sales engagement with distributor networks and digital ordering platforms achieve broader coverage and more consistent inventory performance. Several firms are also leveraging localized production and regional regulatory expertise to reduce order lead times and improve price competitiveness in import-sensitive markets. Finally, firms that offer comprehensive lifecycle support, including warranty programs, clinician education, and post-market surveillance, are perceived as lower operational risk by procurement teams. In sum, company differentiation is less about single product superiority and more about the ability to deliver consistent clinical outcomes, reliable supply continuity, and supportive service models that embed the device into institutional workflows.

High-impact recommendations for device manufacturers and commercial leaders to strengthen clinical differentiation, supply resilience, and value-based adoption

Actionable recommendations for industry leaders emphasize pragmatic steps to strengthen clinical differentiation, supply resilience, and commercial relevance. First, prioritize evidence generation that aligns with payer metrics and hospital value frameworks; invest in registries and targeted randomized studies that demonstrate durable outcomes and cost-effectiveness in representative patient cohorts. Second, diversify manufacturing and supplier networks to reduce exposure to trade policy shifts and logistic disruptions, while maintaining rigorous quality systems and transparent sourcing disclosures to reassure institutional buyers.

Third, tailor product portfolios to distinct clinical and end-user needs by aligning device features-such as polymer strategy, drug elution profile, and material composition-with the procedural settings most relevant to adoption. Fourth, expand commercial models to include a mix of direct sales for complex centers, distributor partnerships for broad reach, and digital platforms for replenishment and product education. Fifth, invest in post-market surveillance and digital tools that produce real-world evidence and support clinician training; these capabilities enhance formulary acceptance and support long-term outcomes tracking. Finally, cultivate collaborative payer and health-system dialogues that frame devices in total care terms rather than unit price, enabling agreements that reward demonstrable clinical and economic value. Implementing these measures will improve market resilience and position organizations to capture sustained clinical adoption.

Robust mixed-method research approach combining clinician interviews, guideline synthesis, regulatory review, and commercial channel analysis to validate conclusions

The research methodology underpinning this report combines qualitative expert interviews, systematic literature appraisal, regulatory document review, and cross-functional commercial analysis to ensure balanced and verifiable insights. Primary engagement included conversations with interventional cardiologists, hospital procurement leaders, distribution executives, and reimbursement specialists to capture frontline perspectives on device selection, clinical priorities, and operational constraints. These stakeholder inputs were triangulated with peer-reviewed clinical literature, guidelines from major cardiology societies, and public regulatory communications to validate clinical assertions and identify emerging safety signals.

Commercial analysis used anonymized supplier and distributor data to map typical go-to-market models, SKU strategies, and channel performance considerations, while supply chain examination incorporated sourcing patterns and manufacturing footprints to assess resilience under changing trade conditions. Care was taken to exclude proprietary or confidential data, and all interpretations were grounded in publicly verifiable sources and subject-matter expert corroboration. Throughout, the methodology prioritized transparency in assumptions, clarity in segmentation, and reproducibility of analytic steps so that findings can inform strategy, procurement, and clinical planning with confidence.

Concluding synthesis highlighting how clinical performance, supply strategy, and service integration together determine long-term adoption and institutional value

In conclusion, the coronary stent sector is navigating a pivotal phase where material science, polymer technology, and evidence generation converge with evolving procurement and regulatory contexts. The clinical imperative remains the primary driver of device selection: durable outcomes, reduced restenosis, and favorable healing profiles will continue to influence cardiologist preference. At the same time, economic and operational factors such as supply chain resilience, total cost of ownership, and regional regulatory complexity are increasingly decisive for hospital and system buyers.

Therefore, stakeholders that align product innovation with demonstrable clinical benefit, transparent supply strategies, and service-oriented commercial models will be best placed to achieve sustainable adoption. Strategic investments in localized manufacturing, real-world evidence generation, and integrated post-sale support will create defensible advantages. Ultimately, the market rewards solutions that deliver predictable clinical outcomes while fitting seamlessly into institutional workflows and payer expectations, ensuring both patient benefit and institutional value realization.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of bioresorbable magnesium stents reducing long-term thrombosis risk
  • 5.2. Integration of drug-eluting coating innovations targeting complex coronary lesions
  • 5.3. Expansion of robotic-assisted percutaneous coronary interventions improving precision
  • 5.4. Growing demand for dual therapy stents addressing restenosis and healing simultaneously
  • 5.5. Advancements in patient-specific stent sizing aided by 3D imaging and AI algorithms
  • 5.6. Market penetration of thin strut cobalt chromium stents enhancing deliverability
  • 5.7. Regulatory approvals shaping opportunities for next-generation biodegradable polymer stents
  • 5.8. Impact of China and India expanding public health programs on coronary stent consumption
  • 5.9. Evolution of remote monitoring and digital health platforms for post-stenting patient follow-up
  • 5.10. Competitive dynamics from low-cost stent manufacturers influencing pricing strategies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Stents Market, by Product Type

  • 8.1. Bare Metal Stents
  • 8.2. Bioresorbable Vascular Scaffold
  • 8.3. Drug Eluting Stents
    • 8.3.1. Polymer Coated
      • 8.3.1.1. Everolimus Eluting
      • 8.3.1.2. Sirolimus Eluting
      • 8.3.1.3. Zotarolimus Eluting
    • 8.3.2. Polymer Free

9. Coronary Stents Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Nitinol
  • 9.3. Stainless Steel

10. Coronary Stents Market, by Coating

  • 10.1. Polymer Coated
  • 10.2. Polymer Free
  • 10.3. Uncoated

11. Coronary Stents Market, by Application

  • 11.1. Acute Myocardial Infarction
  • 11.2. Chronic Coronary Artery Disease

12. Coronary Stents Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Cardiac Centers
  • 12.3. Hospitals

13. Coronary Stents Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online

14. Coronary Stents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Coronary Stents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Coronary Stents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. Boston Scientific Corporation
    • 17.3.3. Medtronic plc
    • 17.3.4. Terumo Corporation
    • 17.3.5. Biotronik SE & Co. KG
    • 17.3.6. Cordis Corporation
    • 17.3.7. B. Braun Melsungen AG
    • 17.3.8. MicroPort Scientific Corporation
    • 17.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
    • 17.3.10. Cook Medical LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CORONARY STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CORONARY STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CORONARY STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS CORONARY STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS CORONARY STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. GCC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. GCC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. GCC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. GCC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. GCC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 324. GCC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 325. GCC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 326. GCC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 327. GCC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 328. GCC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 329. GCC CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 330. GCC CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 331. GCC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. GCC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. GCC CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. GCC CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. GCC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. GCC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPEAN UNION CORONARY STENTS MARKET SIZ